MMP9 and neoplasm: As observed in tumour cells, the invalidation of BASIGIN in MEF does not notably modify the level of MMP2 and MMP9 in extra cellular media (Figure 2A lanes j, k, Figure 3A lanes n, o and Figure 2F–2G, 3F-3G).